Brain Cancer News Individuals exposed to wildfire within 50 km of residential locations in the past 10 years had a slightly higher incidence of lung cancer and brain tumors.
Nearly 70% of patients had at least 1 potentially actionable therapeutic target.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Li-Fraumeni syndrome.
Systemic inflammatory biomarkers may be useful in the differential diagnosis of primary central nervous system lymphoma and high-grade glioma.
Overall and progression-free survival were superior with temozolomide.
The approval was based on data demonstrating that the biosimilar product and the reference product were highly similar, and that there were no clinically meaningful differences between the agents.
Patients who received treatment selected by the ChemoID assay had superior progression-free survival and overall survival.
Researchers found no increased risk of any brain tumors among cell phone users.
Measuring lymphocytes during or after radiotherapy could provide useful information about infection risk, according to researchers.
Maternal obesity and diabetes may increase the risk of cancer, particularly leukemia, in offspring.
Young men had a higher risk of death after any brain tumor diagnosis.
Researchers found that entry into the ventricle space during surgical resection elevated the risk of leptomeningeal disease in patients with melanoma brain metastases.
No significant association was seen between maternal hormonal contraception use and CNS tumors in children younger than 20 years.
HLA-A*03 was associated with worse progression-free and overall survival.
The proportion of patients who reported improvements in fatigue was similar across the treatment arms.
Patients with low-grade and high-grade glioma achieved responses.
Among patients with a performance status of less than 80, 20.6% had an improvement in this metric.
The median PFS was 10.6 months in the nivolumab group and 10.3 months in the placebo group.
Patient satisfaction scores before the pandemic were comparable to scores during the pandemic.
Patients without hematologic recovery had an increased risk of febrile neutropenia, infection, hospitalization, and death.
Load More